Toxicological Effects of Metal Oxide Nanomaterials - Safety of Nanomaterials along Their Lifecycle - page 185

Kroll, A., C. Dierker, C. Rommel, D. Hahn, W. Wohlleben, C. Schulze-Isfort, C. Gobbert, M.
Voetz, F. Hardinghaus, and J. Schnekenburger. 2011. Cytotoxicity screening of 23 engi-
neered nanomaterials using a test matrix of ten cell lines and three different assays. Part
Fibre Toxicol 8 (1):9.
Kroll, A., M. H. Pillukat, D. Hahn, and J. Schnekenburger. 2009. Current in vitro methods
in nanoparticle risk assessment: Limitations and challenges. Eur J Pharm Biopharm
72 (2):370-377.
Kroll, A., M. H. Pillukat, D. Hahn, and J. Schnekenburger. 2012. Interference of engineered
nanoparticles with in vitro toxicity assays. Arch Toxicol 86 (7):1123-1136.
Landsiedel, R., M. D. Kapp, M. Schulz, K. Wiench and F. Oesch. 2009. Genotoxicity inves-
tigations on nanomaterials: Methods, preparation and characterization of test material,
potential artifacts and limitations-Many questions, some answers. Mutat Res Rev Mutat
Res 681 (2-3):241-258.
Landsiedel, R., L. Ma-Hock, A. Kroll, D. Hahn, J. Schnekenburger, K. Wiench, and W.
Wohlleben. 2010. Testing metal-oxide nanomaterials for human safety. Adv Mater
22 (24):2601-2627.
Lanone, S., F. Rogerieux, J. Geys, A. Dupont, E. Maillot-Marechal, J. Boczkowski, G. Lacroix,
and P. Hoet. 2009. Comparative toxicity of 24 manufactured nanoparticles in human
alveolar epithelial and macrophage cell lines. Part Fibre Toxicol 6 (14):1-12.
Limbach, L. K., P. Wick, P. Manser, R. N. Grass, A. Bruinink, and W. J. Stark. 2007.
Exposure of engineered nanoparticles to human lung epithelial cells: Influence of
chemical composition and catalytic activity on oxidative stress. Environ Sci Technol 41
(11):4158-4163.
Lin, W., Y. W. Huang, X. D. Zhou, and Y. Ma. 2006. Toxicity of cerium oxide nanoparticles in
human lung cancer cells. Int J Toxicol 25 (6):451-457.
Lin, W. S., Y. Xu, C. C. Huang, Y. F. Ma, K. B. Shannon, D. R. Chen, and Y. W. Huang.
2009. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells.
J Nanopart Res 11 (1):25-39.
Lindberg, H. K., G. C. Falck, J. Catalan, A. J. Koivisto, S. Suhonen, H. Jarventaus, E. M. Rossi,
H. Nykasenoja, Y. Peltonen, C. Moreno, H. Alenius, T. Tuomi, K. M. Savolainen, and H.
Norppa. 2012. Genotoxicity of inhaled nanosized TiO (2) in mice. Mutat Res 745 (1-2):58-64.
Lundqvist, M., J. Stigler, G. Elia, I. Lynch, T. Cedervall and K. A. Dawson. 2008. Nanoparticle
size and surface properties determine the protein corona with possible implications for
biological impacts. Proc Natl Acad Sci U S A 105 (38):14265-14270.
Madl, A. K. and K. E. Pinkerton. 2009. Health effects of inhaled engineered and incidental
nanoparticles. Crit Rev Toxicol 39 (8):629-658.
Magdolenova, Z., A. Collins, A. Kumar, A. Dhawan, V. Stone, and M. Dusinska. 2013.
Mechanisms of genotoxicity. A review of in vitro and in vivo studies with engineered
nanoparticles. Nanotoxicology 8 (3):233-278.
Ma-Hock, L., A. O. Gamer, R. Landsiedel, E. Leibold, T. Frechen, B. Sens, M. Linsenbuehler,
and B. van Ravenzwaay. 2007. Generation and characterization of test atmospheres with
nanomaterials. Inhal Toxicol 19 (10):833-848.
Maiorano, G., S. Sabella, B. Sorce, V. Brunetti, M. A. Malvindi, R. Cingolani, and P. P. Pompa.
2010. Effects of cell culture media on the dynamic formation of protein-nanoparticle
complexes and influence on the cellular response. ACS Nano 4 (12):7481-7491.
Monteiro-Riviere, N. A., A. O. Inman and L. W. Zhang. 2009. Limitations and relative util-
ity of screening assays to assess engineered nanoparticle toxicity in a human cell line.
Toxicol Appl Pharmacol 234 (2):222-235.
Morfeld, P., S. Treumann, L. Ma-Hock, J. Bruch, and R. Landsiedel. 2012. Deposition behav-
ior of inhaled nanostructured TiO 2 in rats: Fractions of particle diameter below 100 nm
(nanoscale) and the slicing bias of transmission electron microscopy. Inhal Toxicol 24
(14):939-951.